Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Vance Allen Insider Profile
4 Followers
Peter Vance Allen, Director at Clinigen, holds 23.25K shares in Abcam plc (Ticker: GB:ABC), holds 50.73K shares in Clinigen (Ticker: GB:CLIN), holds 413.37K shares in Diurnal (Ticker: GB:DNL).
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+18.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Vance Allen holds in companies
Most Profitable Insider Trade
Stock:
Diurnal
(DNL)
(DNL)
Rating:Informative Buy
Date:Jan 10, 2020 - Jan 10, 2021
Return:+130.60%
The most profitable trade made by Peter Vance Allen
Peter Vance Allen's Trading History
Clinigen
Oct 28, 2020
―
Informative Buy
30.45K
£469.27K
Abcam plc
Apr 05, 2022
―
Uninformative Buy
67.28K
£285.01K
Future plc
Jul 07, 2017
Director
Informative Buy
32.09K
£550.18K
Diurnal
Jan 10, 2020
―
Informative Buy
20.02K
£112.85K
Advanced Medical Solutions
May 14, 2014
Director
Informative Buy
62.15K
£95.20K
Scancell Holdings
Aug 13, 2013
Director
Informative Buy
16.50K
£4.80K
List of latest transactions for each holding click on a transaction to see Peter Vance Allen's performance on stock
You May Also Like
Peter Vance Allen insider profile FAQ
What is the percentage of profitable transactions made by Peter Vance Allen?
The percentage of profitable transactions made by Peter Vance Allen is 64%.
What is the average return per transaction made by Peter Vance Allen?
The average return per transaction made by Peter Vance Allen is 18.30%.
What stocks does Peter Vance Allen hold?
Peter Vance Allen holds: GB:CLIN, GB:ABC, GB:FUTR, GB:DNL, GB:AMS, GB:SCLP stocks.
What was Peter Vance Allen’s latest transaction?
Peter Vance Allen latest transaction was an Uninformative Buy of 67.28K.
What was Peter Vance Allen's most profitable transaction?
Peter Vance Allen’s most profitable transaction was an Informative Buy of GB:DNL stock on January 10, 2020. The return on the trade was 130.60%.
What is Peter Vance Allen's role in Clinigen?
Peter Vance Allen's role in Clinigen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.